From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy
European Journal of Cancer · 2026-05 · 239 · 116711
DOI: 10.1016/j.ejca.2026.116711 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2026-05. Verfasst von Steven C M A Wijnen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Biomarkers, Tumor, Neoplasms, Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 151 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands.
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Hematology and Medical…
Zitieren
APA
Wijnen, S. C. M. A., Dimitriadis, P., Wessels, L. F. A., & Blank, C. U. (2026). From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy. European Journal of Cancer, 239, 116711. https://doi.org/10.1016/j.ejca.2026.116711
Vancouver
Wijnen SCMA, Dimitriadis P, Wessels LFA, Blank CU. From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy. European Journal of Cancer. 2026;239:116711. doi:10.1016/j.ejca.2026.116711
BibTeX
@article{Wijnen2026,
author = {Wijnen, Steven C M A and Dimitriadis, Petros and Wessels, Lodewyk F A and Blank, Christian U},
title = {From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy},
journal = {European Journal of Cancer},
year = {2026},
volume = {239},
pages = {116711},
doi = {10.1016/j.ejca.2026.116711}
}
EUVIMED